Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Hailisheng Pharmaceutical Co., Ltd. is a prominent Chinese pharmaceutical company specializing in the development and manufacture of marine-derived medicines and chemical drugs. As a core subsidiary of the Hailisheng Group, the company leverages its location in Zhoushan to focus on marine biological resources, producing a wide range of products including soft capsules, tablets, and injections. Their portfolio features treatments for liver disease, cardiovascular conditions, and infectious diseases, with a notable emphasis on polyene phosphatidylcholine and omega-3 fatty acids. Hailisheng operates GMP-certified facilities and maintains a strong presence in both the domestic Chinese market and international exports. The company is recognized for its integration of traditional pharmaceutical manufacturing with modern marine biotechnology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Hailisheng Pharmaceutical.